Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene

Annals of Neurology

Volumn 44, Issue 5, 1998, Pages 836-839

  Gambardella, A ^a,b   Mazzei, R ^b   Toscano, A ^c   Annesi, G ^b   Pasqua, A ^b   Annesi, F ^b   Quattrone, F ^d   Oliveri, R L ^b   Valentino, P ^a   Bono, F ^a   Aguglia, U ^a   Zappia, M ^a   Vita, G ^c   Quattrone, A ^a,b,e  

^a School of Medicine   (Italy)

^b CNR   (Italy)

^c Inst Neurol and Neurosurgical Sci   (Italy)

^d Neurorehabilitation Unit   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELL SURVIVAL; CHILD; CHROMOSOME 8; DISEASE SEVERITY; EXON; GENE DELETION; GENE ISOLATION; HUMAN; MALE; MOTONEURON; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY; TELOMERE;

EID: 18244427458     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440522     Document Type: Article

References (15)

1. Munsat TM, Davies KE. Meeting report: International SMA Consortium meeting. Neuromuscul Disord 1992;2:423-428
2. Brzustowicz LM, Lehner T, Castilla LH, et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 1990;344:540-541
3. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-165
4. Iwahashi H, Eguchi Y, Yasuhara N, et al. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 1997;390(6658):413-417
5. Roy N, Mahadevan MS, McLean M, et al. The gene for neuronal apoptosis inhibitor protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995;80:167-178
6. Campbell L, Potter A, Ignatius J, et al. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997; 61:40-50
7. DiDonato CJ, Ingraham SE, Mendell JR, et al. Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity? Ann Neurol 1997;41:230-237
8. Zerres K, Rudnik-Schoneborn S. Spinal muscular atrophy: clinical and genetic correlations. Neuromuscul Disord 1997;7:202-207
9. cBCD541 and SMA phenotype. Hum Mol Genet 1996;5:257-263
10. Bussaglia E, Clement O, Tizzano E, et al. A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 1995;11:335-337
11. van der Steege G, Grootscholten PM, van der Vlies P, et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995;345:985-986
12. Kawaguchi Y, Okamoto T, Tanikawi M, et al. CAG expansion in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-228
13. Banfi S, Servadio A, Chung M, et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet 1994;7:513-520
14. Rastinejad F, Conboy MJ, Rando TA, Blau HM. Tumor suppression by RNA from the 3′ untranslated region of a a-tropomyosin. Cell 1993;75:513-520
15. Parano E, Pavone L, Falsaperla R, et al. Molecular basis of phenotypic heterogeneity in siblings with spinal muscular atrophy. Ann Neurol 1996;40:247-251